Calendar MEI Pharma, Inc.

Equities

MEIP

US55279B3015

Market Closed - Nasdaq 21:30:00 29/04/2024 BST 5-day change 1st Jan Change
3.08 USD +0.98% Intraday chart for MEI Pharma, Inc. -8.61% -46.90%

Chart calendar MEI Pharma, Inc.

99028076f1a328f956dd.c_nEeYn_VkuvNJuBO74w0ZpnE61H0xQTpO7m3Xy5I0A.FqGRKdC9Mw7GGam3VNJhlNAiQcYRp11C0r6AmDvbZjk9kpQS-IcFI_dFqw~4a7ab9f267eeaf63c489e21bc4f1302b

Upcoming events on MEI Pharma, Inc.

08/05/2024 Q3 2024 Earnings Release (Projected)
28/08/2024 Q4 2024 Earnings Release (Projected)
06/11/2024 Q1 2025 Earnings Release (Projected)
05/02/2025 Q2 2025 Earnings Release (Projected)

Past events on MEI Pharma, Inc.

16/04/2024 18:30 Stifel Virtual Targeted Oncology Days Conference
13/02/2024 22:05 Q2 2024 Earnings Release
20/01/2024 14:30 ASCO Gastrointestinal Cancers Symposium - Abstract No - TPS222
18/12/2023 17:00 Annual General Meeting
12/12/2023 02:00 American Society of Hematology Meeting
15/11/2023 Ex-dividend day
15/11/2023 13:35 Stifel Healthcare Conference
09/11/2023 21:05 Q1 2024 Earnings Release
26/09/2023 22:00 Q4 2023 Earnings Call
26/09/2023 21:05 Q4 2023 Earnings Release
23/07/2023 15:00 Extraordinary Shareholders Meeting - M&A Vote
13/07/2023 Extraordinary Shareholders Meeting - M&A Vote
11/05/2023 21:05 Q3 2023 Earnings Release
16/04/2023 Reverse Split: 1 of 20
23/02/2023 13:00 MEI Pharma, Inc. and Infinity Pharmaceuticals, Inc. Merger Call
09/02/2023 21:05 Q2 2023 Earnings Release
05/01/2023 17:00 Annual General Meeting
09/12/2022 American Society of Hematology Meeting - Publication Number: 78
09/12/2022 American Society of Hematology Meeting - Publication Number: 1563
09/12/2022 American Society of Hematology Meeting - Publication Number: 1553

Past dividends on MEI Pharma, Inc.

15/11/2023 1.75 USD

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,92
4,54
8.36%
28,9
39,0
-25.87%
25,5
19,6
30.17%
40,7
41,8
-2.61%
48,8
48,3
1.09%

65,4

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-46,2
-46,4
0.42%
-24,5
-49,9
50.79%
-69,7
-76,1
8.46%
-75,5
-79,2
4.68%
-36,8
-44,7
17.79%

20,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-16,8
-32,2
47.7%
-46,0
9,94
-563.06%
-50,6
-67,0
24.47%
-54,5
-58,7
7.24%
-31,8
-38,0
16.3%

24,4

Net income
Million USD
Released
Forecast
Spread
-16,8
-35,6
52.72%
-46,0
-40,2
-14.57%
-50,6
-64,7
21.78%
-54,5
-60,9
10.63%
-31,8
-38,0
16.3%

24,4

EPS
USD
Released
Forecast
Spread
-4,80
-12,3
60.84%
-10,2
-3,03
-236.79%
-9,00
-11,4
21.25%
-8,80
-9,35
5.88%
-4,78
-5,70
16.07%

3,29

Announcement Date28/08/1909/09/2002/09/2108/09/2226/09/23-

Quarterly results

Fiscal PeriodJunio 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
18,2
4,52
302.77%
9,69
3,06
217.13%
11,4
4,17
173.5%
8,73
4,42
97.6%
32,7
3,34
879.15%
5,89
0,46
1174.85%
1,46
0,93
56.5%
65,3
0,00
-
0,00
0,07
-

0,03


0,03


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-11,2
-23,2
51.53%
-21,6
-26,0
17.07%
-16,2
-27,2
40.38%
-18,2
-24,1
24.34%
8,93
-26,1
134.14%
-16,4
-20,5
19.93%
-11,1
-19,0
41.8%
55,3
-12,9
529.57%
-11,9
-10,3
-16.02%

-11,5


-12,2


-14,2


-14,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,77
-21,9
73.61%
-8,73
-22,6
61.43%
-16,1
-26,0
38.17%
-16,6
-21,7
23.22%
10,3
-28,6
135.8%
-15,4
-19,0
18.57%
-10,0
-16,2
38.22%
56,4
-12,0
569.78%
-11,1
-9,47
-16.88%

-10,7


-11,5


-13,6


-14,3

Net income
Million USD
Released
Forecast
Spread
-5,77
-22,4
74.3%
-8,73
-23,0
62.01%
-16,1
-26,1
38.45%
-16,6
-21,7
23.22%
10,3
-26,4
138.88%
-15,4
-19,0
18.57%
-10,0
-16,2
38.22%
56,4
-12,0
569.78%
-11,1
-9,47
-16.88%

-9,94


-10,6


-10,9


-11,5

EPS
USD
Released
Forecast
Spread
-1,00
-3,84
73.99%
-1,40
-3,65
61.64%
-2,40
-3,85
37.66%
-2,40
-3,25
26.15%
1,60
-4,20
138.1%
-2,32
-2,87
19.07%
-1,51
-2,42
37.6%
8,46
-1,80
571.31%
-1,66
-1,41
-17.45%

-1,49


-1,58


-1,64


-1,72

Announcement Date10/02/2223/05/2208/09/2214/11/2209/02/2311/05/2326/09/2309/11/2313/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MEIP Stock
  4. Calendar MEI Pharma, Inc.